⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL447923 | 1.00 | — | — | |
| SCHEMBL27918470 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL27348202 | 0.97 | — | — | |
| Benzene SCHEMBL28834032 | 0.94 | SLC22A6 (0.50) | — | |
| SCHEMBL288510 | 0.76 | SLC22A6 (0.50) | — | |
| SCHEMBL93579 | 0.76 | — | — | |
| SCHEMBL2491274 | 0.76 | SLC22A6 (0.50) | — | |
| SCHEMBL23225427 | 0.75 | — | — | |
| SCHEMBL4797239 | 0.75 | — | — | |
| SCHEMBL29305546 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018567-A1 | METHODS AND COMPOSITIONS FOR THE DETECTION OF BETA-LACTAMASES | BECTON DICKINSON CO (US) | 2024-01-18 | — | — | US | disclosed |
| US-11572579-B2 | Kits for the detection of beta-lactamases | BECTON, DICKINSON AND COMPANY (US) | 2023-02-07 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-20210155969-A1 | METHODS AND COMPOSITIONS FOR THE DETECTION OF BETA-LACTAMASES | BECTON DICKINSON CO (US) | 2021-05-27 | — | — | US | disclosed |
| US-10704079-B2 | Methods for the detection of beta-lactamases in a sample | BECTON, DICKINSON AND COMPANY (US) | 2020-07-07 | — | — | US | disclosed |
| EP-3512851-A1 | BETA-LACTAMASE INHIBITOR COMPOUNDS | Entasis Therapeutics Limited (GB) | 2019-07-24 | — | — | EP | disclosed |
| US-20180334701-A1 | METHODS AND COMPOSITIONS FOR THE DETECTION OF BETA-LACTAMASES | BECTON DICKINSON CO (US) | 2018-11-22 | — | — | US | disclosed |
| EP-3347008-A1 | BETA-LACTAMASE INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2018-07-18 | — | — | EP | disclosed |
| WO-2018053215-A1 | BETA-LACTAMASE INHIBITOR COMPOUNDS | ENTASIS THERAPEUTICS LIMITED (GB) | 2018-03-22 | — | — | WO | disclosed |
| US-9902989-B2 | Methods for the detection of beta-lactamases | BECTON, DICKINSON AND COMPANY (US) | 2018-02-27 | — | — | US | disclosed |
| US-20090117601-A1 | METHODS AND COMPOSITIONS FOR THE DETECTION OF BETA-LACTAMASES | BECTON, DICKINSON AND COMPANY | 2009-05-07 | — | — | US | disclosed |
| EP-2038411-A1 | MODIFIED BETA-LACTAMASE AND METHOD FOR ITS PREPARATION | Ipsat Therapies Oy (FI) | 2009-03-25 | — | — | EP | disclosed |
| EP-1913137-A1 | SERINE BETA-LACTAMASE-LIKE / D-AIA CARBOXYPEPTIDASE-LIKE PROTEIN | Ares Trading S.A. (CH) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007147945-A1 | MODIFIED BETA-LACTAMASE AND METHOD FOR ITS PREPARATION | IPSAT THERAPIES OY (FI) | 2007-12-27 | — | — | WO | disclosed |
| WO-2007010283-A1 | SERINE BETA-LACTAMASE-LIKE / D-ALA CARBOXYPEPTIDASE-LIKE PROTEIN | ARES TRADING S.A. (CH) | 2007-01-25 | — | — | WO | disclosed |
| EP-1263987-A2 | RANDOM TRUNCATION AND AMPLIFICATION OF NUCLEIC ACID | Genopsys, Inc. (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-1224277-A1 | RANDOM MUTAGENESIS AND AMPLIFICATION OF NUCLEIC ACID | Genopsys (US) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001012802-A9 | RANDOM MUTAGENESIS AND AMPLIFICATION OF NUCLEIC ACID | GENOPSYS (US) | 2002-07-11 | — | — | WO | disclosed |
| WO-2001066798-A2 | RANDOM TRUNCATION AND AMPLIFICATION OF NUCLEIC ACID | GENOPSYS, INC. (US) | 2001-09-13 | — | — | WO | disclosed |
| WO-2001012802-A1 | RANDOM MUTAGENESIS AND AMPLIFICATION OF NUCLEIC ACID | GENOPSYS (US) | 2001-02-22 | — | — | WO | disclosed |